In a report released yesterday, Lisa Gill from J.P. Morgan maintained a Hold rating on InnovAge Holding (INNV – Research Report), with a price target of $5.00. The company’s shares closed last Thursday at $4.56, close to its 52-week low of $3.46.
According to TipRanks.com, Gill is a 5-star analyst with an average return of 16.0% and a 61.7% success rate. Gill covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Alignment Healthcare, and Bright Health Group.
Currently, the analyst consensus on InnovAge Holding is a Hold with an average price target of $5.92.
See the top stocks recommended by analysts >>
The company has a one-year high of $27.18 and a one-year low of $3.46. Currently, InnovAge Holding has an average volume of 815.2K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes.
Read More on INNV:
- J.P. Morgan Remains a Hold on Apartment Income REIT (AIRC)
- J.P. Morgan Thinks Uber Technologies’ Stock is Going to Recover
- J.P. Morgan Maintains a Buy Rating on Lyft (LYFT)
- J.P. Morgan Sticks to Their Buy Rating for Inspire Medical Systems (INSP)
- Avaya Holdings (AVYA) Gets a Hold Rating from J.P. Morgan
